Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000251648 | SCV000315859 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000006170 | SCV000478321 | likely benign | Upshaw-Schulman syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000767050 | SCV000617792 | uncertain significance | not provided | 2021-04-21 | criteria provided, single submitter | clinical testing | Often reported in the literature as a polymorphism with a suspected northeastern Asian origin of the variant (Nakagawa et al., 2016; Tso et al., 2020); Reported in a deceased female infant with diarrhea negative hemolytic uremic syndrome and ADAMTS13 activity that was 54% of normal levels (Choi et al., 2011); Published functional crystal structure studies demonstrate that the P475S mutant destabilizes the protein leading to reduced substrate affinity and moderately reduced catalytic efficiency of the ADAMTS13 enzyme (Akiyama et al., 2013); Published functional cell transfection studies demonstrate the P475S variant resulted in very low enzyme activity (Kokame et al., 2002); In silico analysis supports that this missense variant does not alter protein structure/function; Observed in 2.024% (642/31714 alleles) individuals of Latino background and 1.524% (273/17908 alleles) individuals of East Asian background in the gnomAD dataset, including multiple unrelated homozygous individuals (Lek et al., 2016); This variant is associated with the following publications: (PMID: 12195022, 23715102, 19847791, 18665921, 27497325, 23621748, 22768050, 12181489, 21676167, 18581589, 21488199, 29669506, 29304523, 32588586) |
Mendelics | RCV000006170 | SCV001137945 | benign | Upshaw-Schulman syndrome | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000767050 | SCV003246220 | benign | not provided | 2024-01-22 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000006170 | SCV000026352 | pathogenic | Upshaw-Schulman syndrome | 2002-09-03 | no assertion criteria provided | literature only |